Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1350323

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1350323

North America Companion Animal Drugs Market, By Product Type, By Distribution channels, By country ( U.S., Canada)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

North America Companion Animal Drugs Market is estimated to be valued at US$ 12.1 Billion in 2023 and is expected to exhibit a CAGR of 4.3% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 12.1 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 4.30% 2030 Value Projection: US$ 16.2 Bn
North America Companion Animal Drugs Market - IMG1

Veterinary drugs are a critical factor in animal husbandry and contemporary-day meal production; however, their residues can persist in animal-derived ingredients. To reduce those risks, the countrywide government set up strict controls for the authorization, labeling, and use of veterinary pills in meal-generating animals, and they behavior surveillance packages to discover hazardous drug residues in animal-derived ingredients.

Market Dynamics

Under the Federal Food, Drug, and Cosmetic Act, the term "drug" refers to articles identified within the U.S. Food and Drug Administration, on August 16, 2022, the reputable U.S. Pharmacopoeia, reputable Homeopathic Pharmacopoeia of the U.S., or reputable National Formulary; articles meant to be used within the diagnosis, cure, mitigation, treatment, or prevention of disorder in guys or different animals; and articles aside from meals meant to have an effect on the shape or any feature of the frame of guys or different animals. It additionally consists of articles meant to be used as an element of a drug. Once a product is decided to be a drug for animal use, the subsequent step is to decide whether or not it's far a brand new animal drug. The act defines a brand new animal drug (in part) as any drug meant to be used for animals aside from humans, the composition of which isn't typically identified, amongst professionals certified via means of clinical schooling and experience, as secure and powerful to be used below the situations prescribed, recommended, or advised in its labeling. By distinctive feature of Supreme Court interpretations of the vital foundation for trendy recognition, there are, for all sensible purposes, no animal capsules that aren't additionally new animal capsules.

Key features of the study:

  • This report provides an in-depth analysis of the North America companion animal drugs market and provides market size (US$ billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the North America companion animal drugs market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Zoetis Inc, Merck & Co., Inc, Bayer AG, Eli Lily & Co, Sanofi (Merial), Ceva Sante Animal, Virbac Animal Health, and Boehringer Ingelheim GmbH.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • North America companion animal drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the North America companion animal drugs market.

Detailed Segmentation:

  • North America Companion Animal Drugs Market, By Product Type:
    • Antibiotics
    • Anti-inflammatory
    • Parasiticides
    • Ecto-Parasiticides
    • Endo-Parasiticides
    • Heart worm Products
    • Behavioral Products
    • Nutritional Products
    • Skin care Products
    • Vaccines
  • North America Companion Animal Drugs Market, By Distribution Channel:
    • Veterinary Hospitals
    • Veterinary Clinics
    • Pharmacies and Drug Stores
  • North America Companion Animal Drugs Market, By country:
    • U.S.
    • Canada
  • Company Profiles
    • Zoetis Inc
    • Merck & Co., Inc
    • Bayer AG
    • Eli Lily & Co
    • Sanofi (Merial)
    • Ceva Sante Animal
    • Virbac Animal Health
    • Boehringer Ingelheim GmbH
Product Code: CMI4117

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Distribution Channels
    • Market Snapshot, By Country
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. North America Companion Animal Drugs Market- COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. North America Companion Animal Drugs Market, By Product Type, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Antibiotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Anti-inflammatory
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Parasiticides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Ecto-Parasiticides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Endo-Parasiticides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Heart worm Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Behavioral Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Nutritional Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Skin care Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

6. North America Companion Animal Drugs Market, By Distribution Channel, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Veterinary Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Veterinary Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Pharmacies and Drug Stores
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends

7. North America Companion Animal Drugs Market, By Country, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country, 2018-2030
    • Country Trends
  • U.S
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2018-2030, (US$ Billion)
  • Canada
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2018-2030, (US$ Billion)

8. Competitive Landscape

  • Zoetis Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eli Lily & Co
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi (Merial)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ceva Sante Animal
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Virbac Animal Health
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boehringer Ingelheim GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!